An inventive healthcare diagnostics startup based in Bengaluru & a brand of Uber Diagnostics, Cardiotrack has secured $2 million in pre series A funding round directed by seasoned angel investor Girish Narasimhan. Earlier, the startup had bagged an angel investment of $ 1.6 million from the group of UHNIs. The funding round also saw participation from Co-investor, Y S Shashidhar – Advisor, Dubai Holdings LLC, Former Partner & managing Director, Frost & Sullivan, Middle East, Africa & South Asia Region.

Delivering the most advanced & inclusive home Pathology & Radiology test & screening services, Cardiotrack spanning across more than 300 locations in India.

In the course of its powerful system of diagnostic centers, technicians & phlebotomists advanced with its technology, Cardiotrack is offering the industry’s best biological coverage & stay live around the clock for its health life insurance consumers.

A turn around features such as exclusive screening technologies of Cardiotrack is equivalent of a treadmill test, which can be performed in the home with utmost comfort with video-oriented medical recording examinations.

Stating on this funding acquisition, Avin Agarwal, Founder & CEO, Cardiotrack, states, “We are thrilled to have secured this investment as we continue to innovate and expand our reach in our mission to drive positive change in the healthcare industry. Our revolutionary approach to healthcare screening not only enhances convenience for consumers but also enables health and life insurance providers to offer fast, comprehensive, personalized and advanced health care services, besides increased operational efficiency and improving our healthcare data analytics capabilities for faster and more accurate insurance underwriting. The investment further validates the venture’s direction and the immense value it brings in improving the healthcare experience for both providers and consumers."